Interferon-beta: Clinical Trials

2 trials of Interferon-beta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 withdrawn. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Withdrawn 1

Follow Interferon-beta: new trials by email Literature Review of Interferon-beta trials Research Report on Interferon-beta

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Early Highly Effective Therapies Group, Escalation Therapies Group - Multiple Sclerosis, Relapsing-Remitting
Phase 4Active not recruitingThe Cleveland Clinic8002019-01-032026-08-31
Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy
Interferon Beta, BIIB017 (Peginterferon beta-1a) - Relapsing Multiple Sclerosis
Phase 4WithdrawnBiogen2014-10-012014-11-17

Conditions studied

Multiple Sclerosis, Relapsing-Remitting (1)

Sponsors

Biogen (1)  ·  The Cleveland Clinic (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Daniel Ontaneda, MD, MSc (1)  ·  Nikos Evangelou, MD, DPhil (1)

Results publications

PMID 42218617